Downregulation of CD226 on tumor‐infiltrating CTLs has been reported in several solid malignancies, such as non‐small cell lung carcinoma (NSCLC) [26] squamous cell carcinoma [25], and colorectal cancer [27]. The gene discussed is CD226; the disease is neoplasm.